1. AB1159 High dose glucocorticoids as a risk factor of sigmoid diverticulitis perforations in autoimmune diseases. (15th June 2017) Authors: Kuranobu, T; Ishitoku, M; Tokunaga, T; Yoshida, Y; Hirata, S; Nojima, T; Sugiyama, E Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1460 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of highly radiopure NaI(Tl) scintillator for PICOLON dark matter search project. (16th February 2021) Authors: Fushimi, K; Kanemitsu, Y; Hirata, S; Chernyak, D; Hazama, R; Ikeda, H; Imagawa, K; Ishiura, H; Ito, H; Kisimoto, T; Kozlov, A; Takemoto, Y; Yasuda, K; Ejiri, H; Hata, K; Iida, T; Inoue, K; Koga, M; Nakamura, K; Orito, R Journal: Progress of theoretical and experimental physics Issue: Volume 2021:Number 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of anti-CD20 antibody rituximab for patients with refractory systemic lupus erythematosus. (April 2018) Authors: Iwata, S; Saito, K; Hirata, S; Ohkubo, N; Nakayamada, S; Nakano, K; Hanami, K; Kubo, S; Miyagawa, I; Yoshikawa, M; Miyazaki, Y; Yoshinari, H; Tanaka, Y Journal: Lupus Issue: Volume 27:Number 5(2018) Page Start: 802 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Malignant neurilemmoma of left atrium. Issue 1 (January 1982) Authors: Ishikawa, K; Hirata, S; Fukuzumi, N Journal: Heart Issue: Volume 47:Issue 1(1982) Page Start: 94 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0062 14-3-3ETA predicts joint damage progression and flaring after adalimumab discontinuation. (15th June 2017) Authors: Hirata, S; Marotta, A; Hanami, K; Tanaka, Y Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 791 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. SAT0622 Multicenter 14-3-3ETA biomarker reproducibility; the japanese experience. (15th June 2017) Authors: Hirata, S; Kaneda, M; Isayama, T; Gui, Y; Marotta, A; Maksymowych, WP; Tanaka, Y Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1009 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Tumour necrosis factor α augments the inhibitory effects of CTLA-4-Ig on osteoclast generation from human monocytes via induction of CD80 expression. (27th February 2019) Authors: Oi, K; Tokunaga, T; Kuranobu, T; Yukawa, K; Kohno, H; Yoshida, Y; Mokuda, S; Hirata, S; Sugiyama, E Journal: Clinical and experimental immunology Issue: Volume 196:Number 3(2019) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗